Binary oncolytic adenovirus in combination with HER2-specific autologous CAR VST for treatment of advanced HER2-positive solid tumors (VISTA).

被引：0
|
作者：
Makawita, Shalini
Gibbs, Jerry M.
McFadden, Dustin R.
Porter, Caroline
Shaw, Amanda Rosewell
Robertson, Catherine
Woods, Mae Louise
Wang, Tao
Grilley, Bambi J.
Heslop, Helen E.
Brenner, Malcolm K.
Suzuki, Masataka
机构：
[1] Baylor Coll Med, Houston, TX USA
[2] Houston Methodist Hosp, Houston, TX USA
[3] Baylor Coll Med, Cell & Gene Therapy, Houston, TX USA
[4] Texas Childrens Hosp, Houston, TX USA
[5] Baylor Coll Med, Div Diabet Endocrinol & Metab, Houston, TX USA
[6] Baylor Coll Med, Div Pediat, Houston, TX USA
[7] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX USA
[8] Texas Childrens Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2679
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neratinib plus capecitabine for the treatment of advanced HER2-positive breast cancer
    Oliveira, Mafalda
    Garrigos, Laia
    Assaf, Juan David
    Escriva-de-Romani, Santiago
    Saura, Cristina
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (09) : 731 - 741
  • [32] Low-affinity Her2-specific CAR-T cells for the treatment of breast cancer
    Marzal, B.
    Calderon, H.
    Andreu, I.
    Urbano-Ispizua, A.
    Juan, M.
    Prat, A.
    Guedan, S.
    HUMAN GENE THERAPY, 2019, 30 (11) : A51 - A51
  • [33] New target for advanced colorectal carcinoma: Anti-HER-2 combination effective in HER-2 positive tumors
    Reinacher-Schick A.
    Der Onkologe, 2016, 22 (12): : 994 - 995
  • [34] A RETROSPECTIVE ANALYSIS OF FIRST-LINE TREATMENT IN HER2-POSITIVE AND HER2-NEGATIVE ADVANCED GASTRIC CANCER
    Onodera, K.
    Kawakami, K.
    Yukisawa, S.
    Warita, E.
    Yamanaka, Y.
    ANNALS OF ONCOLOGY, 2013, 24 : 68 - 68
  • [35] Pembrolizumab in combination with trastuzumab for treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer
    Qureshi, Zaheer
    Jamil, Abdur
    Fatima, Eeshal
    Altaf, Faryal
    Siddique, Rimsha
    Shah, Shivendra
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (08): : 4647 - 4656
  • [36] Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors
    Wang, Jianzheng
    Zhang, Baiwen
    Cheng, Xiaojiao
    Li, Qingli
    Lv, Huifang
    Nie, Caiyun
    Chen, Beibei
    Xu, Weifeng
    Zhao, Jing
    He, Yunduan
    Tu, Shuiping
    Chen, Xiaobing
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [37] A phase 1 study of MM-111, a bispecific HER2/HER3 antibody fusion protein, combined with multiple treatment regimens in patients with advanced HER2-positive solid tumors.
    Richards, Donald A.
    Braiteh, Fadi S.
    Garcia, A. A.
    Denlinger, Crystal Shereen
    Conkling, Paul R.
    Edenfield, William Jeffery
    Anthony, Stephen Patrick
    Hellerstedt, Beth A.
    Raju, Robert N.
    Becerra, Carlos
    Harb, Wael A.
    Smith, David A.
    McDonagh, Charlotte Fenton
    Kawash, Kate-Lyn
    Frye, Sasha
    Moyo, Victor M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for HER2-Positive Breast Cancer
    Vieira, Claudia
    Borges, Andreia
    Pereira, Filipa F.
    Antunes, Pedro
    Redondo, Patricia
    Antunes, Luis
    Lopes, Jose M.
    Goncalves, Francisco R.
    Borges, Marina
    Bento, Maria J.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2023, 6 (01) : 1 - 9
  • [39] Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer
    Kutlu, Yasin
    Cekin, Ruhper
    Aydin, Sabin Goktas
    Shbair, Abdallah T. M.
    Bilici, Ahmet
    Arici, Serdar
    Oven, Bala Basak
    Acikgoz, Ozgur
    Ozcan, Erkan
    Olmez, Omer Fatih
    Cakir, Asli
    Seker, Mesut
    CURRENT PROBLEMS IN CANCER, 2024, 50
  • [40] Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects
    Brandao, Mariana
    Ponde, Noam F.
    Poggio, Francesca
    Kotecki, Nuria
    Salis, Mauren
    Lambertini, Matteo
    de Azambuja, Evandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (07) : 629 - 649
12345